A randomized study of cyclosporine and methotrexate with or without methylprednisolone for the prevention of graft‐versus‐host disease: Improved long‐term survival with triple prophylaxis

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|124|4|727-733

ISSN： 0008-543x

Source： CANCER, Vol.124, Iss.4, 2018-02, pp. : 727-733

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA‐identical sibling donor allogeneic hematopoietic cell transplantation

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 2, 2015-02 ,pp. : 144-148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mycophenolate‐based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative‐related donor stem cell transplantation

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 5, 2015-05 ,pp. : 392-399

John Wiley & Sons Inc

Access to resources Recommend Favorite

The efficacy and safety of sirolimus‐based graft‐versus‐host disease prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation: a meta‐analysis of randomized controlled trials

By  

TRANSFUSION, Vol. 41-1132, Iss. 9, 2015-09 ,pp. : 2134-2141

John Wiley & Sons Inc

Access to resources Recommend Favorite

The efficacy and safety of sirolimus‐based graft‐versus‐host disease prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation: a meta‐analysis of randomized controlled trials

By  

TRANSFUSION, Vol. 55, Iss. 9, 2015-09 ,pp. : 2134-2141

John Wiley & Sons Inc

Access to resources Recommend Favorite

Infections after T‐replete haploidentical transplantation and high‐dose cyclophosphamide as graft‐versus‐host disease prophylaxis

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 2, 2015-04 ,pp. : 242-249

John Wiley & Sons Inc

Access to resources Recommend Favorite